Search - tctmd.com

Displaying 301 - 320 of 466

Sort: Relevancy | Date

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Industry News

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

March 05, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Shelley Wood

January 01, 2019

News Features

Top News in Structural Heart Disease: 2018

L.A. McKeown

December 28, 2018

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

News Daily News

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

Caitlin E. Cox

December 06, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

News Daily News

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Michael O'Riordan

November 09, 2018

News Industry News

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

November 06, 2018

News Daily News

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Yael L. Maxwell

October 19, 2018

Advertisement

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Top News in Structural Heart Disease: 2018

Better TAVR Outcomes With More Experienced Operators: New York Database

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content